Beximco Pharmaceuticals Ltd. (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building the presence in many emerging and developed markets around the world. Beximco Pharma is consistently building upon its portfolio and currently producing more than 500 products encompassing broad therapeutic categories and the Company has created strong differentiation by offering a range of high-tech, specialized products which are difficult to imitate.

Beximco Pharma is a leading edge pharmaceutical company, the first UFDA approved company of Bangladesh is acclaimed for outstanding product quality, world-class manufacturing facilities, product development capabilities and excellent service. We produce and market 'branded generics' for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets.

Beximco Pharma is pleased to announce the launching of its ‘Virology’ unit to become your partner for helping people to lead a life without viral hepatitis with a vision of increasing accessibility of viral hepatitis medication more accessible to general people with world class quality products.